Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Silverman

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Journal of Health Economics and Outcomes Research|September 5, 2022
Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with OsteoarthritisStuart Silverman, Patricia Schepman, J Bradford Rice, et al.
Pharmacoeconomics|February 4, 2023
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature ReviewNannan Li, Charlotte Beaudart, Jane A Cauley, et al.
Pharmacoeconomics|November 8, 2014
A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosisMickaël Hiligsmann, Silvia M Evers, Wafa Ben Sedrine, et al.
Current Osteoporosis Reports|December 9, 2009
Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone lossMone Zaidi, Charles H Turner, Ernesto Canalis, et al.
Journal of Occupational and Environmental Medicine|June 22, 2022
All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With OsteoarthritisStuart Silverman, Sheena Thakkar, Heather Sell, et al.
Pharmacoeconomics|March 4, 2023
Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature ReviewNannan Li, Charlotte Beaudart, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Making the first fracture the last fracture: ASBMR task force report on secondary fracture preventionJohn A Eisman, Earl R Bogoch, Rick Dell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 5, 2021
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysisLouis P Garrison, Patricia Schepman, Andrew G Bushmakin, et al.
Bone|July 19, 2018
Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studiesBente L Langdahl, Stuart Silverman, Saeko Fujiwara, et al.
Calcified Tissue International|October 22, 2018
Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational StudiesStuart Silverman, Bente L Langdahl, Saeko Fujiwara, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Journal of Health Economics and Outcomes Research|September 5, 2022
Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with OsteoarthritisStuart Silverman, Patricia Schepman, J Bradford Rice, et al.
Pharmacoeconomics|February 4, 2023
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature ReviewNannan Li, Charlotte Beaudart, Jane A Cauley, et al.
Pharmacoeconomics|November 8, 2014
A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosisMickaël Hiligsmann, Silvia M Evers, Wafa Ben Sedrine, et al.
Current Osteoporosis Reports|December 9, 2009
Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone lossMone Zaidi, Charles H Turner, Ernesto Canalis, et al.
Journal of Occupational and Environmental Medicine|June 22, 2022
All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With OsteoarthritisStuart Silverman, Sheena Thakkar, Heather Sell, et al.
Pharmacoeconomics|March 4, 2023
Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature ReviewNannan Li, Charlotte Beaudart, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Making the first fracture the last fracture: ASBMR task force report on secondary fracture preventionJohn A Eisman, Earl R Bogoch, Rick Dell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 5, 2021
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysisLouis P Garrison, Patricia Schepman, Andrew G Bushmakin, et al.
Bone|July 19, 2018
Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studiesBente L Langdahl, Stuart Silverman, Saeko Fujiwara, et al.
Calcified Tissue International|October 22, 2018
Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational StudiesStuart Silverman, Bente L Langdahl, Saeko Fujiwara, et al.
Pageof 10